Homepage News

Post Archives


Tech’s arsenal in the fight against cancer

Friday, June 24th, 2016

Written by Roberto Torres, Technical.ly Philly 

As humanity embarks on a cancer moonshot, some of the needed solutions might be simpler than you think. An event hosted by PACT explored the frontiers of cancer treatment.

When it comes to cancer, it seems like everyone has a story that hits home.

For Dr. Howard Krein, chief medical officer of StartUp Health, the main element in the narrative was the frustration he felt when even all the resources in the world meant nothing.

See, Krein’s brother-in-law, Beau Biden — son of Vice President Joe Biden — began a drawn-out battle against an aggressive type of brain cancer in 2010.

Help was offered from the world’s top physicians, but there was a small problem: There was no quick way to get the result of Beau’s brain scans to those who could help. In an era where an emoji can travel the world in a heartbeat, life-or-death medical reports had to be put in boxes and shipped to where they were needed, due to their complexity.

Out of this frustration, and the sadness of Biden’s tragic 2015 demise, the National Cancer Moonshot Initiative was born, in a bid to provide technology with all the support it needed to stand tough in the face of cancer.

Click here to read the full article.

Posted in Homepage News, News | No Comments »

How TierPoint Quietly Built a Data Center Empire in Secondary Markets

Friday, June 24th, 2016

Written by Bill Stoller, Data Center Knowledge 

While the current cloud data center leasing frenzy involving the six publicly traded data center REITs in the biggest markets tends to command the headlines, it’s easy to lose sight of other major trends in the data center industry. One of them is the amount of activity in secondary data center markets.

Example of a company that’s been successful at taking advantage of that trend is St. Louis, Missouri-based TierPoint, a private equity-backed colocation, hybrid cloud, and managed services provider that has quickly become a force to be reckoned with in the data center industry. Over the last year or so, it has accelerated pace and scale of acquisitions, while also expanding through new construction and development. Most notably, it recently completed a 70,000-square foot facility on a 15-acre campus in Oklahoma City.

Gartner recently recognized TierPoint in its June 2016 “Magic Quadrant for Disaster Recovery as a Service” report. As Shea Long, TierPoint’s senior VP of product, put it in an interview with Data Center Knowledge, the company sees DRaaS as one of the key “mousetraps” in its expansion strategy.

Click here to read the full article.

Posted in Homepage News, News | No Comments »

CloudMine Named Recipient of the 2016 SIIA CODiE Award for Best Information Service Delivered as Mobile App or Platform

Friday, June 24th, 2016

CloudMine earns prestigious industry recognition from Software & Information Industry Association (SIIA)

CloudMine, healthcare’s secure data platform, was named Best Information Service Delivered as Mobile App or Platform of 2016 as part of the 2016 SIIA CODiE Awards.

With the Connected Health Cloud, for the first time, all parties across the healthcare chain will have the technology they need to bring together disparate data and apply powerful analysis to improve patient care.

The winner announcement was made on May 18 by the Software & Information Industry Association (SIIA), the principal trade association for the software and digital content industries, to an audience of over 400 leaders. 61 awards were given for products and services deployed specifically for B2B software, information and media companies.

An SIIA CODiE Award win is a prestigious honor, as each award winner was reviewed by a field of industry experts whose evaluations determined the finalists. SIIA members then reviewed the finalists and their votes were combined with the scores from the industry experts to select this year’s CODiE Awards winners.

“We’re honored to be receiving a CODiE Award by SIIA for enabling all parties in the healthcare chain to deliver accurate, personalized and intelligent health solutions,” said Brendan McCorkle, CEO of CloudMine. “With the launch of our Connected Health Cloud, we are reducing time-to-delivery by up to 70 percent and therefore allowing developers to build robust, HIPAA-compliant web, mobile and IoT applications.”

Click here to read the full press release.

Posted in Homepage News, Member Press Releases, News | No Comments »

SAP’s Venture Arm Sapphire Plans to Invest $100 Million Into VC Funds

Friday, June 24th, 2016

Written by Leena Rao, FORTUNE

Sapphire Ventures, a firm whose sole backer is enterprise giant SAP, said Wednesday that it would deploy $100 million this year into eight to nine early stage venture capital funds.

Sapphire Ventures, formerly known as SAP Ventures, is somewhat unique in the venture world in that it is both an investor in technology companies as well as an investor in early stage funds. SAP is the firm’s sole backer and provider of capital, but Sapphire’s managing director Beezer Clarkson insists that the firm has complete independence from SAP. That means that SAP isn’t considered a strategic investor, doesn’t weigh in on investment decisions, and isn’t involved with the day-to-day operations of the firm.

Through its $650 million fund, Sapphire Ventures has invested in Fitbit, Box, Criteo, Docusign, and others. The firm, which currently manages over $1.4 billion, has also deployed capital as a limited partner or LP into a number of VC funds including August Capital, Data Collective, LA-based Amplify, and Berlin-based Point Nine Capital.

Click here to read the full article.

Posted in Homepage News, News | No Comments »

Martina F. Aufiero Joins Safeguard Scientifics as Managing Director, Technology

Tuesday, June 21st, 2016

Brings more than 20 years of investment and operational experience in financial and enterprise technology

Radnor, PA, June 20, 2016 — Safeguard Scientifics, Inc. (NYSE:SFE) today announced that Martina F. Aufiero has joined the company as Senior Vice President and Managing Director, Technology. Ms. Aufiero will be responsible for sourcing and deploying capital in early- and growth-stage technology companies, providing operational oversight and driving successful exits for Safeguard’s partner companies.

Ms. Aufiero brings more than 20 years of experience to Safeguard, most recently serving as Managing Director and Head of Corporate Development for a leading New York-based financial technology firm, where she led several key acquisitions and inorganic growth initiatives. Previously, Ms. Aufiero served as Vice President of Principal Strategic Investing at Goldman Sachs (NYSE: GS), where she led numerous investments in the financial technology sector as part of a $1.0 billion portfolio. On behalf of Goldman Sachs, Ms. Aufiero served on the Boards of Directors for APX Inc., the Green Exchange LLC, Medley Global Advisors LLC and LiquidityMatch LLC and as a board alternate on FXAll Inc. Her experience as a board member includes Audit Committee Chair and leadership roles on Compensation and Investment Committees, as well as holding a corporate officer position for a consortium of 11 global banks. Prior to joining Goldman Sachs, Ms. Aufiero was the Director of Mergers & Acquisitions for Moneyline Telerate (acquired by Reuters in 2004). Previously, she was a Manager in the strategy consulting practice of Andersen Consulting and held several roles with the Atlantic Richfield Company (ARCO).

Click here to read the full press release.

Posted in Homepage News, Member Press Releases, News | No Comments »

Safeguard Scientifics leads $17.5M financing for Aktana

Tuesday, June 21st, 2016

Aktana Raises $17.5M To Fund Growing Decision Support Business In Life Sciences

JUN 08, 2016

New Capital Targets International Expansion and Continued Product Development

Founded in 2011, Aktana focuses exclusively on the life sciences market, which has contributed to multi-year growth rates of more than 100%, and relationships with seven of the world’s top 15 pharmaceutical companies. Aktana helps these customers improve their commercial effectiveness by delivering data-driven insights and suggestions directly to sales reps, coordinating multi-channel actions, and providing insight regarding which strategies work best for which customers under which conditions.

San Francisco, CA, June 8, 2016 — Aktana, the pioneer in decision support for global life science companies, today announced a $17.5 million financing led by Safeguard Scientifics, Inc. (NYSE: SFE), which will initially deploy up to $8.25 million. Existing investor Starfish Ventures and others are also participating in the financing. Closing is expected on or before June 16, 2016. Aktana will use proceeds from the financing primarily for continued product development and international expansion. The company plans to open offices in China and Europe, adding to its current offices in San Francisco, New York City, and Tokyo.

Click here to read the full press release.

Posted in Homepage News, Member Press Releases, News | No Comments »

CNN Political Commentator, Michael Smerconish, to Keynote IMPACT 2016 Conference

Tuesday, June 21st, 2016

Award-Winning Radio and Television Commentator Michael Smerconish to Share Insights at IMPACT 2016 Breakfast on November 30th

PHILADELPHIA, PA – June 21, 2015 – Philadelphia Alliance for Capital and Technologies (PACT) announced today that Michael Smerconish, Host of The Michael Smerconish Program on SiriusXM Channel 124 and Host of CNN’s Smerconish, will serve as the keynote speaker at the IMPACT 2016 Breakfast on Wednesday, November 30th.

As an award-winning commentator, Smerconish has often been recognized for his radio work. He has been the recipient of several (Philadelphia) Achievements in Radio awards, including Best Talk Show Host and Best Evening Program. Philadelphia Magazine has named him the city’s best talk show host, as well as one of the city’s most powerful citizens. On August 20, 2009, Smerconish became the first radio host to interview President Barack Obama live from the White House. He has also interviewed Presidents Jimmy Carter, George H.W. Bush, Bill Clinton and George W. Bush, as well as Vice Presidents Al Gore, Dick Cheney and Joe Biden. Smerconish has been an MSNBC contributor and frequent guest-host of Hardball for Chris Matthews. He has been a guest on virtually every television program where politics is discussed, including: the NBC Today show, Colbert Report, O’Reilly Factor, Larry King Live, The View, and Real Time With Bill Maher.

Click here to read Michael Smerconish’s full biography.

“We are honored to welcome Michael as this year’s Breakfast Keynote Speaker. His insights into the political world will bring great value to the IMPACT Capital Conference. The 2016 political race has been the model of Growth through Disruption. We are excited to hear Michael’s analysis,” explained Sean Denham, Chairman, and Dave Maturo, Vice Chairman of the IMPACT 2016 Capital Conference. Denham serves as Philadelphia Office Managing Partner of Grant Thornton and Maturo serves as Director of Business Development of Grant Thornton.

Read here the press release.

Posted in Homepage News, IMPACT News, News, PACT Press Releases | No Comments »

Main Line software firm raises $12M

Monday, June 20th, 2016

written by John George, Philadelphia Business Journal 

Relay Network, a Montgomery County software company that helps businesses and customers communicate securely in real time, raised $12 million in a private stock sale.

The financing was led be existing investors NewSpring Capital or Radnor, Pa., and Philadelphia-based First Round Capital along with Independence Health, parent company of Independence Blue Cross, the region’s largest health insurer.

Relay Network, also of Radnor, has now raised a total of $28.7 million since its inception in 2010. The company plans to use funds to continue scaling its technology platform and operations.

“Businesses are realizing a huge opportunity to improve customer relationships by making them feel more like personal interactions,” said Matt Gillin, CEO and co-founder of Relay Network, in a statement.

Click here to read the full article.

Posted in Homepage News, News | No Comments »

Pfizer is automating clinical trials through the use of Pega

Monday, June 20th, 2016

Clinical trials and drug development is a lengthy and expensive business. Pharmaceutical companies can spend hundreds of millions of dollars developing just one drug for the market. And the process, as it stands, requires complicated engagement from a variety of stakeholders and isn’t currently organised in any efficient fashion.

However, that’s changing. A consortium of 19 pharmaceutical companies have come together to standardise on things that they don’t consider to be a competitive advantage, so as to further progress drug development and research. Pfizer is one of the first companies to take this on-board and is building a technology enablement platform around those standardised concepts.

That platform is being enabled by Pegasystems, which should allow the pharmaceutical group to streamline its processes, take out inefficiency and potentially introduce massive time and money savings into creating new drugs for the market.

Click here to read the full article.

Posted in Homepage News, News | No Comments »

Intact Vascular’s Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial Commences Enrollment with First European Implant of the Tack Endovascular System™

Friday, June 10th, 2016

The TOBA III clinical trial studies the combination of Intact Vascular’s Tack Endovascular System and the Medtronic IN.PACT® Admiral® Drug-Coated Balloon in the treatment of Peripheral Artery Disease (PAD)

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has commenced enrollment, with the first patient treated by Prof. Klaus Brechtel at the Franziskus-Hospital in Berlin, Germany.

The TOBA III study is a prospective, multi-center, single-arm study designed to investigate the safety and efficacy of the Tack Endovascular System in combination with the Medtronic Admiral drug-coated angioplasty balloon in the treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries. The Tack Endovascular System is a new technology designed to repair dissections (or tears) in the artery wall that frequently occur as a complication of balloon angioplasty. The system allows physicians to repair these dissections while leaving a minimal amount of foreign material in the artery, reducing mechanical stress on the artery, and preserving future treatment options.

Click here to read the full press details.

Posted in Homepage News, Member Press Releases, News | No Comments »